company background image
543329 logo

Windlas Biotech BSE:543329 Stock Report

Last Price

₹533.70

Market Cap

₹11.1b

7D

-3.6%

1Y

114.9%

Updated

14 Apr, 2024

Data

Company Financials

Windlas Biotech Limited

BSE:543329 Stock Report

Market Cap: ₹11.1b

543329 Stock Overview

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally.

543329 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

Windlas Biotech Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Windlas Biotech
Historical stock prices
Current Share Price₹533.70
52 Week High₹590.00
52 Week Low₹244.45
Beta0.49
1 Month Change2.61%
3 Month Change11.54%
1 Year Change114.90%
3 Year Changen/a
5 Year Changen/a
Change since IPO31.23%

Recent News & Updates

Recent updates

Shareholder Returns

543329IN Life SciencesIN Market
7D-3.6%1.1%-0.03%
1Y114.9%20.7%46.9%

Return vs Industry: 543329 exceeded the Indian Life Sciences industry which returned 20.7% over the past year.

Return vs Market: 543329 exceeded the Indian Market which returned 46.9% over the past year.

Price Volatility

Is 543329's price volatile compared to industry and market?
543329 volatility
543329 Average Weekly Movement7.7%
Life Sciences Industry Average Movement6.2%
Market Average Movement6.8%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 543329 has not had significant price volatility in the past 3 months.

Volatility Over Time: 543329's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20011,049Komal Guptawindlas.com

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products.

Windlas Biotech Limited Fundamentals Summary

How do Windlas Biotech's earnings and revenue compare to its market cap?
543329 fundamental statistics
Market cap₹11.11b
Earnings (TTM)₹526.38m
Revenue (TTM)₹6.00b

21.1x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543329 income statement (TTM)
Revenue₹6.00b
Cost of Revenue₹3.82b
Gross Profit₹2.18b
Other Expenses₹1.66b
Earnings₹526.38m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)25.31
Gross Margin36.37%
Net Profit Margin8.77%
Debt/Equity Ratio1.5%

How did 543329 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

20%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.